Clinical Trial Update: Vaccine Against Escherichia Coli Infection [Phase 1]

View source ↗

Summary

Phase 1 trial update for a vaccine targeting Escherichia coli infections. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Escherichia Coli Infections

Drugs mentioned

• Vaccine Against Escherichia Coli Infection

Snippet

Sponsor: GlycoVaxyn AG | Conditions: E.Coli Infections | Phase 1 | Status: COMPLETED